CanDrivR-CS : a cancer-specific machine learning framework for distinguishing recurrent and rare variants

Read full text
Authors: Amy Francis, Colin Campbell, Tom R. Gaunt
Cited by: 0
References: 34

Abstract

Abstract Motivation Missense variants play a crucial role in cancer development, and distinguishing between those that frequently occur in cancer genomes and those that are rare may provide valuable insights into important functional mechanisms and consequences. Specifically, if common variants confer growth advantages, they may have undergone positive selection across different patients due to similar selection pressures. Moreover, studies have demonstrated the significance of rare mutations that arise as resistance mechanisms in response to drug treatment. This highlights the importance of understanding the role of both recurrent and rare variants in cancer. In addition to this, most existing tools for variant prediction focus on distinguishing variants found in normal and disease populations, often without considering the specific disease contexts in which these variants arise. Instead, they typically build predictors that generalise across all diseases. Here, we introduce CanDrivR-CS , a set of cancer-specific gradient boosting models designed to distinguish between rare and recurrent cancer variants. Results We curated missense variant data from the International Cancer Genome Consortium (ICGC). Cancer-type-specific models significantly outperformed a baseline pan-cancer model, achieving a maximum leave-one-group-out cross-validation (LOGO-CV) F1 score of up to 90% for CanDrivRSKCM (Skin Cutaneous Melanoma) and 89% for CanDrivR-SKCA (Skin Adenocarcinoma) , compared to 79.2% for the baseline model. Notably, DNA shape properties consistently ranked among the top features for distinguishing recurrent and rare variants across all cancers. Specifically, recurrent missense variants frequently occurred in DNA bends and rolls, potentially implicating regions prone to DNA replication errors and acting as mutational hotspots. Availability and Implementation All training and test data, and Python code are available in our CanDrivR-CS GitHub repository: https://github.com/amyfrancis97/CanDrivR-CS .

Fields of Study & Subjects

Cancer Genomics and Diagnostics Genomics and Rare Diseases BRCA gene mutations in cancer

Publication details

Journal / source
Bioinformatics Advances
Volume
6
Issue
1
Pages
vbag008–vbag008
Publication date
1 January 2026
Language
EN